Chengda Pharmaceuticals (301201.SZ): Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) intends to reduce its holdings by no more than 7.27%.

Zhtng Cijng APP News, Chengda Pharmaceutical (301201.SZ) announced that Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership), a shareholder holding 11.0069 million shares of the company (representing 7.27% of the total share capital excluding the repurchased shares), plans to reduce its holdings of the company's shares by no more than 11.0069 million shares (representing 7.27% of the total share capital excluding the repurchased shares) through centralized bidding or block trading within 3 months after 15 trading days from the date of the announcement (September 29, 2025 to December 28, 2025).